Stockscreener 앱 받기
5.42
5.74%
-0.33
Mimedx Group Inc 주식(MDXG)의 최신 뉴스
Aug Chart Watch: Whats the beta of MiMedx Group Inc stock2025 Sector Review & Momentum Based Trading Ideas - baoquankhu1.vn
Recent 8.9% pullback isn't enough to hurt long-term MiMedx Group (NASDAQ:MDXG) shareholders, they're still up 70% over 3 years - Yahoo Finance
MiMedx Group (NASDAQ:MDXG) Hits New 12-Month LowHere's What Happened - MarketBeat
Quarterly Recap: How risky is MiMedx Group Inc stock now2025 Momentum Check & Capital Protection Trade Alerts - Bộ Nội Vụ
MiMedx Group, Inc (MDXG) Stock Analysis: A Biotech Gem With 96.67% Upside Potential - DirectorsTalk Interviews
Trading the Move, Not the Narrative: (MDXG) Edition - Stock Traders Daily
MiMedx Group, Inc Updates Investor Presentation - TradingView — Track All Markets
MiMedx Group, Inc. (NASDAQ:MDXG) Q3 2025 Earnings Call Transcript - MSN
Retail Surge: Can MiMedx Group Inc stock continue upward trend2025 Price Action Summary & Free Expert Approved Momentum Trade Ideas - moha.gov.vn
Upcoming EventsMiMedx Group, IncCommon Stock (Nasdaq:MDXG) Price Chart - FinancialContent
Investors Interested In MiMedx Group, Inc.'s (NASDAQ:MDXG) Earnings - simplywall.st
Take Profit: Will MiMedx Group Inc. stock outperform Nasdaq indexMarket Activity Summary & Free High Accuracy Swing Entry Alerts - Улправда
Aug Wrap: What risks investors should watch in MiMedx Group Inc. stockJuly 2025 Highlights & Real-Time Sentiment Analysis - Улправда
Can MiMedx Group Inc. stock continue upward trendDividend Hike & Daily Growth Stock Investment Tips - Улправда
Jobs Data: Will MiMedx Group Inc. stock outperform Nasdaq indexWeekly Trade Review & Target Return Focused Stock Picks - ulpravda.ru
Can MiMedx Group Inc. stock hit analyst price targetsJuly 2025 Action & Low Risk Profit Maximizing Plans - ulpravda.ru
MiMedx Group Inc Is Quietly Going Off: Is MDXG the Sleeper Stock You’re Sleeping On? - AD HOC NEWS
MiMedx Group, Inc (MDXG) Stock Analysis: Exploring a Potential 92.73% Upside with Strong Buy Ratings - DirectorsTalk Interviews
MiMedx Group, Inc. (NASDAQ:MDXG) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap? - 富途牛牛
(MDXG) Volatility Zones as Tactical Triggers - Stock Traders Daily
Institution Moves: Can MiMedx Group Inc stock continue upward trendCPI Data & Daily Market Momentum Tracking - Bộ Nội Vụ
Harbor Capital Advisors Inc. Cuts Holdings in MiMedx Group, Inc $MDXG - MarketBeat
MiMedx (MDXG) Faces Increased Competition After CMS Policy Change - GuruFocus
Northland Securities Remains a Buy on MiMedx Group (MDXG) - The Globe and Mail
MIMEDX Enters into Exclusive U.S. Distribution Agreement for RegenKit®-Wound Gel - Sahm
MiMedx Group Signs Exclusive Agreement to Distribute Regen Lab USA's RegenKit-Wound Gel in US - marketscreener.com
MiMedx (MDXG) Secures Exclusive Deal for U.S. Distribution of Re - GuruFocus
MiMedx signs exclusive U.S. distribution deal for RegenKit-Wound Gel - Investing.com
MiMedx signs exclusive U.S. distribution deal for RegenKit-Wound Gel By Investing.com - Investing.com South Africa
MiMedx Group, Inc. Partners with Regen Lab USA LLC to Distribute RegenKit®-Wound Gel in the U.S. - Quiver Quantitative
Mimedx Enters into Exclusive U.S. Distribution Agreement for Regenkit®?-Wound Gel - marketscreener.com
(MDXG) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
Value Recap: Why MiMedx Group Inc stock remains undervaluedWeekly Risk Report & Weekly Top Performers Watchlists - moha.gov.vn
Will MiMedx Group Inc. stock gain from lower inflationJuly 2025 Breakouts & Short-Term Trading Alerts - Улправда
With 47% stake, MiMedx Group, Inc. (NASDAQ:MDXG) seems to have captured institutional investors' interest - Yahoo Finance
Will MiMedx Group Inc. stock deliver consistent dividendsJuly 2025 Retail & Expert Approved Momentum Ideas - Улправда
MIMEDX reports immunomodulatory effects of placental allografts By Investing.com - Investing.com Nigeria
What risks investors should watch in MiMedx Group Inc. stockJuly 2025 Price Swings & Short-Term Trading Opportunity Alerts - DonanımHaber
MIMEDX reports immunomodulatory effects of placental allografts - Investing.com
MiMedx (MDXG) Highlights New Study Showcasing Immunomodulatory B - GuruFocus
MiMedx Group, Inc. Announces New Research Supporting Immunomodulatory Effects of Amniotic Membrane Allografts - Quiver Quantitative
MIMEDX Announces Publication in the Journal of Inflammation - GlobeNewswire
MIMEDX Announces Publication in the Journal of Inflammation Focused on Immunomodulatory Effects of Purion® Processed Human Amniotic Membrane Allografts In Vitro - Sahm
Fundamentals Check: Can MiMedx Group Inc. stock maintain operating margins2025 Analyst Calls & Fast Entry Momentum Trade Alerts - ulpravda.ru
Can MiMedx Group Inc. stock maintain operating marginsSell Signal & Growth Oriented Trading Recommendations - Улправда
Mizuho Maintains MiMedx Group (MDXG) Outperform Recommendation - Nasdaq
MiMedx Group (NASDAQ:MDXG) Price Target Lowered to $10.00 at Mizuho - MarketBeat
MiMedx price target lowered to $10 from $12 at Mizuho - TipRanks
Is MiMedx Group, Inc.'s (NASDAQ:MDXG) Recent Stock Performance Tethered To Its Strong Fundamentals? - simplywall.st
Divisadero Street Capital Management LP Boosts Stock Position in MiMedx Group, Inc $MDXG - MarketBeat
Trigran Investments Inc. Has $51.27 Million Holdings in MiMedx Group, Inc $MDXG - MarketBeat
MiMedx Group (MDXG) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Why MiMedx Group Inc. stock remains undervaluedWeekly Trade Analysis & Proven Capital Preservation Tips - Newser
4.73%
0.92%
자본화:
|
볼륨(24시간):